Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWetherspoon (J.D) Regulatory News (JDW)

Share Price Information for Wetherspoon (J.D) (JDW)

Share Price is delayed by 15 minutes
Get Live Data
669.00    8.50 (1.29%)
Bid:
669.50
Ask:
670.50
Spread: 1.00 (0.149%)
Market Cap: £705.16m
JDW Live PriceLast checked at - London Stock Exchange

Intraday Wetherspoon (J.D) Share Chart

Director/PDMR Shareholding

21 Oct 2022 10:28

RNS Number : 7228D
Wetherspoon (JD) PLC
21 October 2022
 

For immediate release

 

J D Wetherspoon plc ("the Company")

 

Notification of transactions of directors, persons discharging managerial responsibility (PDMR) or connected persons

 

J D Wetherspoon plc was notified on 21st October 2022 (that as part of the Company's partnership shares plan, whereby employees are able to purchase ordinary shares in the Company using deductions from monthly salary at the then prevailing market price), EES Corporate Trustees Limited acquired the following ordinary shares of the Company on behalf of directors and PDMRs at a price per ordinary share of 468.68 pence on 18th October 2022:

 

 

Name

Role

No. of ordinary shares purchased

Tom Ball

People Director

22

Michael Barron

Commercial Director

32

Paul Brimmer

Purchasing Director

32

David Capstick

IT & Property Director

32

Nigel Connor

Company Secretary/Legal Director

33

Will Fotheringham

Associate Employee Director

22

Martin Geoghegan

Operations Director

32

John Hutson

Chief Executive Officer

32

Ben Whitley

Finance Director

32

Debbie Whittingham

Employee Director

32

Hannah Young

Deputy Finance Director

22

 

This monthly notification is made pursuant to Article 19.3 Market Abuse Regulation.

 

Enquiries:

Nigel Connor

Company Secretary

Tel.: 01923 477777

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCBDGXDDDGDB
Date   Source Headline
29th Jan 20257:00 amRNSTotal Voting Rights
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTrading Update Announcement
22nd Jan 20257:00 amRNSDirector/PDMR Shareholding
13th Jan 20251:04 pmRNSHolding(s) in Company
18th Dec 202412:41 pmRNSDirector/PDMR Shareholding
2nd Dec 202411:09 amRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
22nd Nov 20242:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20247:00 amRNSResult of AGM - Replacement
21st Nov 20244:31 pmRNSResult of AGM
13th Nov 202410:51 amRNSTotal Voting Rights
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 202412:46 pmRNSDirector/PDMR Shareholding
8th Nov 20247:42 amRNSTransaction in Own Shares
7th Nov 20242:53 pmRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTrading Update Announcement
4th Nov 20248:23 amRNSHolding(s) in Company
4th Nov 20248:18 amRNSHolding(s) in Company
1st Nov 202412:36 pmRNSHolding(s) in Company
31st Oct 20244:53 pmRNSHolding(s) in Company
28th Oct 20244:00 pmRNSNotice of AGM
25th Oct 20241:51 pmRNSStatement re Press Comment
22nd Oct 20243:07 pmRNSDirector/PDMR Shareholding
18th Oct 20248:44 amRNSHolding(s) in Company
15th Oct 20249:19 amRNSDirector/PDMR Shareholding
11th Oct 202410:52 amRNSDirector/PDMR Shareholding
4th Oct 20249:50 amRNSDirector/PDMR Shareholding
4th Oct 20249:39 amRNSAnnual Financial Report
4th Oct 20247:00 amRNSPreliminary results
3rd Oct 20244:27 pmRNSHolding(s) in Company
25th Sep 20243:40 pmRNSDirector/PDMR Shareholding
16th Sep 20243:18 pmRNSHolding(s) in Company
19th Aug 202410:31 amRNSDirector/PDMR Shareholding
9th Aug 20242:56 pmRNSNews release - correction
29th Jul 202410:00 amRNSHolding(s) in Company
29th Jul 202410:00 amRNSDirector/PDMR Shareholding
22nd Jul 202411:08 amRNSDirector/PDMR Shareholding
15th Jul 20242:30 pmRNSStatement re Press Comment
11th Jul 20247:48 amRNSDirector/PDMR Shareholding
11th Jul 20247:00 amRNSReplacement Director/PDMR Shareholding
10th Jul 20244:16 pmRNSDirector/PDMR Shareholding
10th Jul 20247:00 amRNSPre-close trading update
20th Jun 202410:54 amRNSDirector/PDMR Shareholding
5th Jun 20244:21 pmRNSHolding(s) in Company
4th Jun 20242:42 pmRNSHolding(s) in Company
23rd May 20243:09 pmRNSHolding(s) in Company
23rd May 202411:14 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.